BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
tatva chin pharm chem ltd stock

TATVA CHIN PHARM CHEM LTD Share Price

905.5 2.04 (0.22%)
Dec 12 2024 03:29 PM Chemicals NSE: TATVA

TATVA CHIN PHARM CHEM LTD Share Price Update

As of the latest trading session, TATVA CHIN PHARM CHEM LTD share price is currently at 905.5, which is up by 2.04 from its previous closing. Today, the stock has fluctuated between 869.65 and 910.00. Over the past year, TATVA CHIN PHARM CHEM LTD has achieved a return of -43.74 %. In the last month alone, the return has been 3.35 %. Read More...

TATVA CHIN PHARM CHEM LTD Performance

Day Range

Low869.65 High910.00
903.05

52 Week Range

Low 788.50 High 1650.85
903.05

TATVA CHIN PHARM CHEM LTD Share Price

5162

543321

TATVA

img img img img
No Data Available

Open Price

908.20

Prev. Close

903.45

Volume (Shares)

25873.00

Total traded value

233.64

Upper Circuit

1084.10

Lower Circuit

722.80

Note: The current prices & values are delayed, Login to your account for live updates.

TATVA CHIN PHARM CHEM LTD Fundamentals


(Standalone)

Market Cap (Cr) 2118.15
PE Ratio (TTM) 158.79
Book Value / Share 308.43
Beta 0.28
ROE 4.77%
EPS (TTM) 5.68
Dividend Yield 0.22%
Net Profit Qtr (Cr) -1.11

TATVA CHIN PHARM CHEM LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 80.96
Operating Expense 83.34
Net Profit -1.11
Net Profit Margin (%) -1.37
Earnings Per Share (EPS) -0.47
EBITDA 5.39
Effective Tax Rate (%) 29.74
Particulars JUN 2024 (Values in Cr)
Revenue 93.81
Operating Expense 93.09
Net Profit 1.51
Net Profit Margin (%) 1.60
Earnings Per Share (EPS) 0.64
EBITDA 9.11
Effective Tax Rate (%) 29.43
Particulars MAR 2024 (Values in Cr)
Revenue 93.93
Operating Expense 86.17
Net Profit 8.25
Net Profit Margin (%) 8.78
Earnings Per Share (EPS) 3.52
EBITDA 18.73
Effective Tax Rate (%) 32.81
Particulars DEC 2023 (Values in Cr)
Revenue 86.07
Operating Expense 80.72
Net Profit 4.65
Net Profit Margin (%) 5.40
Earnings Per Share (EPS) 1.99
EBITDA 13.52
Effective Tax Rate (%) 29.11
Particulars SEP 2023 (Values in Cr)
Revenue 92.57
Operating Expense 81.62
Net Profit 8.20
Net Profit Margin (%) 8.85
Earnings Per Share (EPS) 3.63
EBITDA 21.50
Effective Tax Rate (%) 29.88
Particulars MAR 2024 (Values in Cr)
Revenue 378.68
Operating Expense 343.92
Net Profit 29.35
Net Profit Margin (%) 7.75
Earnings Per Share (EPS) 12.82
EBITDA 74.38
Effective Tax Rate (%) 30.56
Particulars MAR 2023 (Values in Cr)
Revenue 403.04
Operating Expense 366.30
Net Profit 40.47
Net Profit Margin (%) 10.04
Earnings Per Share (EPS) 18.26
EBITDA 56.76
Effective Tax Rate (%) -4.19
Particulars MAR 2022 (Values in Cr)
Revenue 427.81
Operating Expense 335.17
Net Profit 95.99
Net Profit Margin (%) 22.43
Earnings Per Share (EPS) 44.65
EBITDA 116.40
Effective Tax Rate (%) 7.04
Particulars MAR 2021 (Values in Cr)
Revenue 291.19
Operating Expense 236.94
Net Profit 51.36
Net Profit Margin (%) 17.63
Earnings Per Share (EPS) 25.57
EBITDA 70.29
Effective Tax Rate (%) 13.46
Particulars MAR 2020 (Values in Cr)
Revenue 253.84
Operating Expense 210.18
Net Profit 34.96
Net Profit Margin (%) 13.77
Earnings Per Share (EPS) 17.41
EBITDA 52.94
Effective Tax Rate (%) 20.91
Particulars MAR 2024 (Values in Cr)
Book Value / Share 315.10
ROE % 4.85
ROCE % 6.99
Total Debt to Total Equity 0.15
EBITDA Margin 19.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 232.25
ROE % 9.21
ROCE % 8.34
Total Debt to Total Equity 0.29
EBITDA Margin 14.86
Particulars MAR 2022 (Values in Cr)
Book Value / Share 213.44
ROE % 30.00
ROCE % 25.64
Total Debt to Total Equity 0.33
EBITDA Margin 27.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 82.62
ROE % 36.85
ROCE % 27.90
Total Debt to Total Equity 0.64
EBITDA Margin 23.93
Particulars MAR 2020 (Values in Cr)
Book Value / Share 146.48
ROE % 38.29
ROCE % 28.34
Total Debt to Total Equity 0.85
EBITDA Margin 21.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 310.31
ROE % 4.77
ROCE % 6.90
Total Debt to Total Equity 0.15
EBITDA Margin 19.68
Particulars MAR 2023 (Values in Cr)
Book Value / Share 227.74
ROE % 8.31
ROCE % 7.48
Total Debt to Total Equity 0.30
EBITDA Margin 14.12
Particulars MAR 2022 (Values in Cr)
Book Value / Share 211.54
ROE % 30.43
ROCE % 25.71
Total Debt to Total Equity 0.33
EBITDA Margin 27.26
Particulars MAR 2021 (Values in Cr)
Book Value / Share 80.61
ROE % 37.16
ROCE % 27.74
Total Debt to Total Equity 0.65
EBITDA Margin 24.21
Particulars MAR 2020 (Values in Cr)
Book Value / Share 142.44
ROE % 36.02
ROCE % 26.72
Total Debt to Total Equity 0.86
EBITDA Margin 20.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 38.29
Total Assets 818.71
Total Liabilities 818.71
Total Equity 737.08
Share Outstanding 23392055
Price to Book Ratio 3.48
Return on Assets (%) 3.70
Return on Capital (%) 4.04
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 44.76
Total Assets 758.85
Total Liabilities 758.85
Total Equity 514.79
Share Outstanding 22165062
Price to Book Ratio 7.32
Return on Assets (%) 5.99
Return on Capital (%) 6.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 176.98
Total Assets 658.30
Total Liabilities 658.30
Total Equity 473.08
Share Outstanding 22165062
Price to Book Ratio 10.91
Return on Assets (%) 14.56
Return on Capital (%) 16.17
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.34
Total Assets 314.80
Total Liabilities 314.80
Total Equity 165.96
Share Outstanding 20087500
Price to Book Ratio 0.00
Return on Assets (%) 16.60
Return on Capital (%) 20.4
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 10.82
Total Assets 248.93
Total Liabilities 248.93
Total Equity 117.69
Share Outstanding 8035000
Price to Book Ratio 0.00
Return on Assets (%) 15.18
Return on Capital (%) 19.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 36.97
Total Assets 815.06
Total Liabilities 815.06
Total Equity 725.88
Share Outstanding 23392055
Price to Book Ratio 3.48
Return on Assets (%) 3.60
Return on Capital (%) 3.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 38.58
Total Assets 754.85
Total Liabilities 754.85
Total Equity 504.78
Share Outstanding 22165062
Price to Book Ratio 7.32
Return on Assets (%) 5.36
Return on Capital (%) 5.99
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 174.74
Total Assets 676.20
Total Liabilities 676.20
Total Equity 468.87
Share Outstanding 22165062
Price to Book Ratio 10.91
Return on Assets (%) 14.19
Return on Capital (%) 16.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.58
Total Assets 309.68
Total Liabilities 309.68
Total Equity 161.93
Share Outstanding 20087500
Price to Book Ratio 0.00
Return on Assets (%) 16.58
Return on Capital (%) 20.37
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 9.81
Total Assets 245.30
Total Liabilities 245.30
Total Equity 114.44
Share Outstanding 8035000
Price to Book Ratio 0.00
Return on Assets (%) 14.25
Return on Capital (%) 18.06
Particulars MAR 2024 (Values in Cr)
Net Income 43.56
Cash from Operations 107.90
Cash from Investing -120.54
Cash from Financing 30.51
Net change in Cash 8.02
Free Cash Flow 236.41
Particulars MAR 2023 (Values in Cr)
Net Income 44.77
Cash from Operations 37.07
Cash from Investing -101.14
Cash from Financing 37.79
Net change in Cash -35.56
Free Cash Flow 240.18
Particulars MAR 2022 (Values in Cr)
Net Income 104.12
Cash from Operations 38.78
Cash from Investing -196.80
Cash from Financing 234.96
Net change in Cash 58.53
Free Cash Flow 127.94
Particulars MAR 2021 (Values in Cr)
Net Income 60.69
Cash from Operations 29.50
Cash from Investing -20.65
Cash from Financing -4.71
Net change in Cash -5.67
Free Cash Flow 50.47
Particulars MAR 2020 (Values in Cr)
Net Income 47.59
Cash from Operations 33.51
Cash from Investing -40.18
Cash from Financing 9.95
Net change in Cash -4.91
Free Cash Flow 81.68
Particulars MAR 2024 (Values in Cr)
Net Income 42.26
Cash from Operations 111.02
Cash from Investing -120.54
Cash from Financing 30.54
Net change in Cash 12.78
Free Cash Flow 239.53
Particulars MAR 2023 (Values in Cr)
Net Income 38.83
Cash from Operations 31.47
Cash from Investing -101.12
Cash from Financing 37.81
Net change in Cash -39.57
Free Cash Flow 234.55
Particulars MAR 2022 (Values in Cr)
Net Income 103.26
Cash from Operations 37.72
Cash from Investing -196.68
Cash from Financing 235.01
Net change in Cash 58.04
Free Cash Flow 126.88
Particulars MAR 2021 (Values in Cr)
Net Income 59.34
Cash from Operations 28.72
Cash from Investing -20.61
Cash from Financing -4.71
Net change in Cash -6.42
Free Cash Flow 49.69
Particulars MAR 2020 (Values in Cr)
Net Income 44.21
Cash from Operations 32.02
Cash from Investing -40.18
Cash from Financing 9.70
Net change in Cash -5.84
Free Cash Flow 80.19
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 7489.20 58.33 3.93 22049.52 5183.10 / 8165.25
BASF INDIA LTD 5611.40 37.96 6.92 24289.30 2870.00 / 8748.10
ORIENTAL AROMATICS LTD 465.00 40.65 2.38 1564.89 296.65 / 656.00
DEEPAK FERTILIZERS & PETR 1357.55 25.28 3.01 17137.42 453.20 / 1443.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 275.95 116.93 6.77 24.84 125.60 / 330.00
ATUL LTD 7489.20 52.18 3.96 22049.52 5183.10 / 8165.25
BASF INDIA LTD 5611.40 37.95 6.92 24289.30 2870.00 / 8748.10
BHAGWATI OXYGEN LTD. 53.66 0.00 3.01 12.40 37.15 / 84.68

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 898.90
  • 26 Days 875.30
  • 10 Days 890.00
  • 50 Days 907.00
  • 12 Days 882.40
  • 100 Days 950.40
  • 20 Days 877.20
  • 200 Days 1246.60
909.63
PIVOT
First Resistance 922.27
Second Resistance 941.08
Third Resistance 953.72
First Support 890.82
Second Support 878.18
Third Support 859.37
RSI 55.94
MACD 7.08
Commodity Channel Index (CCI) 106.96
ADX 24.34
Williams % R -21.15

Over 1 Month

down

3.35

Over 3 Months

down

-6.18

Over 6 Months

down

-10.54

Over 1 Year

down

-43.74

Over 3 Years

down

-28.34

Over 5 Years

down

0.00

TATVA CHIN PHARM CHEM LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

TATVA CHIN PHARM CHEM LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
17.82
Promoter Holdings
72.02
FII
3.33
DII
6.82
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Shekhar Rasiklal Somani Shareholding of Promoter and Promoter Group 5396861.0 23.07
Chintan Nitinkumar Shah Shareholding of Promoter and Promoter Group 4897219.0 20.94
Ajay Mansukhlal Patel Shareholding of Promoter and Promoter Group 4000000.0 17.1
Nippon Life India Trustee Ltd-a/c Nippon India Elss Tax Saver Fund Public Shareholding 1007831.0 4.31
Priti Ajay Patel Shareholding of Promoter and Promoter Group 900000.0 3.85
Ajay Mansukhlal Patel (huf) Shareholding of Promoter and Promoter Group 715345.0 3.06
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio Public Shareholding 593879.0 2.54
Chintan N Shah (huf) Shareholding of Promoter and Promoter Group 447500.0 1.91
Icici Prudential Smallcap Fund Public Shareholding 424406.0 1.81
Shital Chintan Shah Shareholding of Promoter and Promoter Group 231000.0 0.99
Kajalben Shekharkumar Somani Shareholding of Promoter and Promoter Group 218080.0 0.93
Darshana Nitinkumar Shah Shareholding of Promoter and Promoter Group 39628.0 0.17
Somani Samir Rasiklal Shareholding of Promoter and Promoter Group 482.0 0.0
Shitalbhai Rasiklal Somani Shareholding of Promoter and Promoter Group 843.0 0.0

TATVA CHIN PHARM CHEM LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-08 2.0 Final 2023-09-08 Equity shares 2022-09-08 2.0 Final 2022-09-09 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About TATVA CHIN PHARM CHEM LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by TATVA CHIN PHARM CHEM LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Tatva Chintan Pharma Chem Ltd?

Answer Field

The share price of Tatva Chintan Pharma Chem Ltd for NSE is ₹ 905.5 and for BSE is ₹ 905.

What is the Market Cap of Tatva Chintan Pharma Chem Ltd?

Answer Field

The market cap of Tatva Chintan Pharma Chem Ltd for NSE is ₹ 21,18.15 Cr. and for BSE is ₹ 21,16.98 Cr. as of now.

What is the 52 Week High and Low of Tatva Chintan Pharma Chem Ltd?

Answer Field

The 52 Week High and Low of Tatva Chintan Pharma Chem Ltd for NSE is ₹ 1650.85 and ₹ 788.50 and for BSE is ₹ 1647.95 and ₹ 789.05.

How to Buy Tatva Chintan Pharma Chem Ltd share?

Answer Field

You can trade in Tatva Chintan Pharma Chem Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Tatva Chintan Pharma Chem Ltd?

Answer Field

The 1 year returns on the stock has been -43.74%.

What is the Current Share Price of Tatva Chintan Pharma Chem Ltd?

Answer Field

Tatva Chintan Pharma Chem Ltd share price is for NSE ₹ 905.5 & for BSE ₹ 905 as on Dec 12 2024 03:29 PM.

What is the Market Cap of Tatva Chintan Pharma Chem Ltd Share?

Answer Field

The market cap of Tatva Chintan Pharma Chem Ltd for NSE ₹ 21,18.15 & for BSE ₹ 21,16.98 as on Dec 12 2024 03:29 PM.

What is the P/E Ratio of Tatva Chintan Pharma Chem Ltd Share?

Answer Field

As on Dec 12 2024 03:29 PM the price-to-earnings (PE) ratio for Tatva Chintan Pharma Chem Ltd share is 158.79.

What is the PB ratio of Tatva Chintan Pharma Chem Ltd Share?

Answer Field

As on Dec 12 2024 03:29 PM, the price-to-book (PB) ratio for Tatva Chintan Pharma Chem Ltd share is 308.43.

How to Buy Tatva Chintan Pharma Chem Ltd Share?

Answer Field

You can trade in Tatva Chintan Pharma Chem Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Tatva Chintan Pharma Chem Ltd Share on Bajaj Broking App?

Answer Field

To buy Tatva Chintan Pharma Chem Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Tatva Chintan Pharma Chem Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader